Results 51 to 60 of about 410,972 (315)

Rare Case of Rickettsiosis Caused by Rickettsia monacensis, Portugal, 2021

open access: yesEmerging Infectious Diseases, 2022
We report a case of rickettsiosis caused by Rickettsia monacensis in an immunocompetent 67-year-old man in Portugal who had eschar, erythematous rash, and an attached Ixodes ricinus tick.
Rita de Sousa   +8 more
doaj   +1 more source

Disordered social media use and risky drinking in young adults:Differential associations with addiction-linked traits [PDF]

open access: yes, 2018
Background Excessive or compulsive use of social media has been likened to an addiction, similar to other behavioural addictions such as pathological gambling or Internet addiction.
Lyvers, Michael   +2 more
core   +1 more source

Discordance between systemic lupus erythematosus disease activity index domain weights and their association with organ damage accrual

open access: yesArthritis Care &Research, Accepted Article.
Objective Studies of damage accrual in patients with systemic lupus erythematosus (SLE) show associations with disease activity measured by the SLE Disease Activity Index 2000 (SLEDAI‐2K), but these associations are imperfect. SLEDAI scores are powerfully influenced by weightings (1‐8) assigned to each domain.
Kevin Zhang   +8 more
wiley   +1 more source

An unusual presentation of a case of human psittacosis [PDF]

open access: yes, 2018
Background: Chlamydia psittaci is a gram-negative, obligate intracellular organism. Birds are the main reservoir, but also non-avian domestic animals and humans can be infected.
Boelens, Jerina   +7 more
core   +3 more sources

Soft Ionic and Electronic Triboelectric Nanogenerators: Toward Attachable and Implantable Biomedical Applications

open access: yesAdvanced Materials, EarlyView.
This review provides an overview of triboelectric nanogenerator (TENG)–based biomedical applications by classifying studies into electronic and ionic systems across attachable and implantable platforms. It summarizes key material choices, device structures, and working mechanisms that characterize current TENG‐based research, and outlines six future ...
Kyongtae Choi   +12 more
wiley   +1 more source

Adverse Drug Reaction Trends in Geriatric Patients: A 5-year Retrospective Study from Eastern India

open access: yesJournal of the Indian Academy of Geriatrics
Background: Geriatric patients exhibit distinct pharmacokinetic and pharmacodynamic characteristics, often further complicated by comorbidities and polypharmacy, making them especially susceptible to adverse drug reactions (ADRs).
Liya Bhaumik   +3 more
doaj   +1 more source

Anti‐PD‐1 Nanobody‐Armored MSLN CAR‐T Therapy for Malignant Mesothelioma: Preclinical and Clinical Studies

open access: yesAdvanced Science, EarlyView.
A novel therapy using engineered immune cells (NAC‐T cells) showed promise for refractory malignant mesothelioma. Based on the encouraging preclinical data, the first‐in‐human trial is initiated, demonstrating tolerable safety and promising anti‐tumor activity (ORR 63.6%, DCR 100%, including one CR).
Yan Sun   +23 more
wiley   +1 more source

Drug reaction with eosinophilia and systemic symptoms syndrome

open access: yesIndian Journal of Rheumatology, 2019
Drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome is a delayed form of severe cutaneous adverse reaction (SCAR) seen in association with certain drugs, especially anticonvulsants and allopurinol.
K C Shanoj   +2 more
doaj   +1 more source

Allergic skin rash with lamotrigine and concomitant valproate therapy - Evidence for an increased risk [PDF]

open access: yes, 1996
Cutaneous rash is one of the commonest adverse events associated with lamotrigine. We assessed whether the risk is increased in patients receiving concomitant valproate therapy in a population of 103 adult patients with intractable epilepsy, who had ...
Duncan, JS   +4 more
core  

Family rash [PDF]

open access: yesEuropean Journal of Internal Medicine, 2021
Fabrizio, Elia   +2 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy